Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A2FM
|
|||
Former ID |
DNC003667
|
|||
Drug Name |
6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one
|
|||
Synonyms |
indole, 20; CHEMBL72278; SCHEMBL4454291; BDBM16454; HXNAGYMCTAINEA-UHFFFAOYSA-N; Heterocyclic Sulfonylpyridazinone, 19a; 6-(indole-2-sulfonyl)-2H-pyridazin-3-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H9N3O3S
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C=C(N2)S(=O)(=O)C3=NNC(=O)C=C3
|
|||
InChI |
1S/C12H9N3O3S/c16-10-5-6-11(15-14-10)19(17,18)12-7-8-3-1-2-4-9(8)13-12/h1-7,13H,(H,14,16)
|
|||
InChIKey |
HXNAGYMCTAINEA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aldose reductase (AKR1B1) | Target Info | Inhibitor | [1] |
BioCyc | Methylglyoxal degradation III | |||
Acetone degradation I (to methylglyoxal) | ||||
KEGG Pathway | Pentose and glucuronate interconversions | |||
Fructose and mannose metabolism | ||||
Galactose metabolism | ||||
Glycerolipid metabolism | ||||
Metabolic pathways | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
Pathwhiz Pathway | Fructose and Mannose Degradation | |||
Pyruvate Metabolism | ||||
Pterine Biosynthesis | ||||
Glycerolipid Metabolism | ||||
Galactose Metabolism | ||||
WikiPathways | Metapathway biotransformation | |||
Polyol Pathway | ||||
Metabolism of steroid hormones and vitamin D |
References | Top | |||
---|---|---|---|---|
REF 1 | A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3... J Med Chem. 2005 Oct 6;48(20):6326-39. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.